Palatin Technologies, Inc

(AMEX:PTN)

0.08

-0.01 (-11.21%)

2:43ET Delayed

Open
0.10
High
0.10
Low
0.08
Vol.
64.40K
Mkt Cap
6.84M
52Wk High
1.05
52Wk Low
0.06
Avg. Vol.
165.70K
P/E (Trailing)
—
Beta
-0.15
Short %
—
Div. Yield
—

Company Profile

Palatin Technologies, Inc

4C Cedarbrook Drive

Cranbury, NJ 08512

United States - Map

Phone: (609) 495-2200

Fax: (609) 495-2201

Website: www.palatin.com

State of incorporation: Delaware

CEO: Dr. Carl Spana, Ph.D.

Employees: 46

Sector: Healthcare

Industry Group: Drugs

Industry: Diagnostic Substances

Dev stage biopharmaceutical co.dev cancer products

A biopharmaceutical company, engaged in the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.

Recent news for PTN

Recent opinions on PTN

No recent Opinions for PTN

Top members owning PTN

Members owning PTN also own

NVD (100.00%), QDHC (100.00%), YMI (100.00%), ATSI (100.00%), GNBT (100.00%)

Member sentiment: Neutral